1 Sacco RL, Kasner SE, Broderick JP, et al. An updateddefinition of stroke for the 21st century:a statementfor healthcare professionals from the American HeartAssociation/American Stroke Association[J]. Stroke,2013, 44:2064-2089.2 Gupta D, Agarwal R, Aggarwal AN, et al. Guidelinesf o r d i a g n o s i s a n d ma n a g eme n t of c h r o n i cobstructive pulmonary disease:Joint ICS/NCCP (I)recommendations[J]. Lung India, 2013, 30:228-267.3 Yang G, Wang Y, Zeng Y, et al. Rapid health transitionin China, 1990-2010:findings from the Global Burdenof Disease Study 2010[J]. Lancet, 2013, 381:1987-2015.4 Fumagalli G, Fabiani F, Forte S, et al. INDACOproject:a pilot study on incidence of comorbiditiesin COPD patients, referred to pneumology units[J].Multidiscip Respir Med, 2013, 8:28.5 Wannamethee SG, Shaper AG, Ebrahim S. Respiratoryfunction and risk of stroke[J]. Stroke, 1995, 26:2004-2010.6 Gulsvik AK, Gulsvik A, Skovlund E, et al. Theassociation between lung function and fatal stroke ina community followed for 4 decades[J]. J EpidemiolCommunity Health, 2012, 66:1030-1036.7 Truelsen T, Prescott E, Lange P, et al. Lung functionand risk of fatal and non-fatal stroke. The CopenhagenCity Heart Study[J]. Int J Epidemiol, 2001, 30:145-151.8 Donaldson GC, Hurst JR, Smith CJ, et al. Increasedrisk of myocardial infarction and stroke followingexacerbation of COPD[J]. Chest, 2010, 137:1091-1097.9 Wedzicha JA, Seemungal TA, MacCallum PK, et al.Acute exacerbations of chronic obstructive pulmonarydisease are accompanied by elevations of plasmafibrinogen and serum IL-6 levels[J]. Thromb Haemost,2000, 84:210-215.10 Wedzicha JA, Donaldson GC. Exacerbations ofchronic obstructive pulmonary disease[J]. RespirCare, 2003, 48:1204-1213.11 Piñol-Ripoll G, de la Puerta I, Santos S, et al. Chronicbronchitis and acute infections as new risk factors forischemic stroke and the lack of protection offered bythe influenza vaccination[J]. Cerebrovasc Dis, 2008,26:339-347.12 Hozawa A, Billings JL, Shahar E, et al. Lung functionand ischemic stroke incidence:the Atherosclerosis Riskin Communities study[J]. Chest, 2006, 130:1642-1649.13 Lahousse L, van den Bouwhuijsen QJ, Loth DW,et al. Chronic obstructive pulmonary disease andlipid core carotid artery plaques in the elderly:theRotterdam Study[J]. Am J Respir Crit Care Med,2013, 187:58-64.14 Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflowlimitation in smokers is associated with subclinicalatherosclerosis[J]. Am J Respir Crit Care Med, 2009,179:35-40.15 Grau AJ, Preusch MR, Palm F, et al. Association ofsymptoms of chronic bronchitis and frequent flu-likeillnesses with stroke[J]. Stroke, 2009, 40:3206-3210.16 Thomsen M, Ingebrigtsen TS, Marott JL. Inflammatorybiomarkers and exacerbations in chronic obstructivepulmonary disease[J]. JAMA, 2013, 309:2353-2361.17 Gan WQ, Man SF, Senthilselvan A, et al. Associationbetween chronic obstructive pulmonary disease andsystemic inf lammation:a systematic review and ameta-analysis[J]. Thorax, 2004, 59:574-580.18 梁汝庆, 丁新生. 炎症因子与缺血性卒中神经损伤研究进展[J]. 神经损伤与功能重建, 2011, 2:147-151.19 Bharosay A, Saxena K, Varma M, et al. Correlationbetween proinf lammatory serum markers:highsensitivity C-reactive protein, interleukin-6 withdisability score in acute ischemic stroke[J]. Indian JClin Biochem, 2011, 26:279-282.20 Isajevs S, Taivans I, Strazda G. Decreased FOXP3expression in small airways of smokers with COPD[J].Eur Respir J, 2009, 33:61-67.21 Li Q, Wang Y, Yu F, et al. Peripheral Th17/Tregimbalance in patients with atherosclerotic cerebralinfarction[J]. Int J Clin Exp Pathol, 2013, 6:1015-1027.22 Li P, Gan Y, Sun BL, Zhang F, et al. Adoptiveregulatory T-cell therapy protects against cerebralischemia[J]. Ann Neurol, 2013, 74:458-471.23 Ji R, Shen H, Pan Y, et al. Novel risk score to predictpneumonia after acute ischemic stroke[J]. Stroke,2013, 44:1303-1309.24 Katzan IL, Cebul RD, Husak SH, et al. The effect ofpneumonia on mortality among patients hospitalizedfor acute stroke[J]. Neurology, 2003, 60:620-625. |